Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin.

Published

Journal Article

The adipocyte-derived secretory factor adiponectin promotes insulin sensitivity, decreases inflammation and promotes cell survival. No unifying mechanism has yet explained how adiponectin can exert such a variety of beneficial systemic effects. Here, we show that adiponectin potently stimulates a ceramidase activity associated with its two receptors, AdipoR1 and AdipoR2, and enhances ceramide catabolism and formation of its antiapoptotic metabolite--sphingosine-1-phosphate (S1P)--independently of AMP-dependent kinase (AMPK). Using models of inducible apoptosis in pancreatic beta cells and cardiomyocytes, we show that transgenic overproduction of adiponectin decreases caspase-8-mediated death, whereas genetic ablation of adiponectin enhances apoptosis in vivo through a sphingolipid-mediated pathway. Ceramidase activity is impaired in cells lacking both adiponectin receptor isoforms, leading to elevated ceramide levels and enhanced susceptibility to palmitate-induced cell death. Combined, our observations suggest a unifying mechanism of action for the beneficial systemic effects exerted by adiponectin, with sphingolipid metabolism as its core upstream signaling component.

Full Text

Cited Authors

  • Holland, WL; Miller, RA; Wang, ZV; Sun, K; Barth, BM; Bui, HH; Davis, KE; Bikman, BT; Halberg, N; Rutkowski, JM; Wade, MR; Tenorio, VM; Kuo, M-S; Brozinick, JT; Zhang, BB; Birnbaum, MJ; Summers, SA; Scherer, PE

Published Date

  • January 2011

Published In

Volume / Issue

  • 17 / 1

Start / End Page

  • 55 - 63

PubMed ID

  • 21186369

Pubmed Central ID

  • 21186369

Electronic International Standard Serial Number (EISSN)

  • 1546-170X

International Standard Serial Number (ISSN)

  • 1078-8956

Digital Object Identifier (DOI)

  • 10.1038/nm.2277

Language

  • eng